Information about Ustekinumab

Generic Name : Ustekinumab
Up-to-date prescription details regarding Ustekinumab are provided here.

Pronunciation : US-te-KIN-ue-mab

Learn the correct pronunciation of the Ustekinumab, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, warnings and its and its storage instructions.

You will also find a list of the medication's International and Indian brand or trade names, as well as its pricing information. For verification of the information presented on this page or for additional clarifications, it's advisable to consult your doctor.

ICD Code : Y43.4 Therapeutic Classification : Monoclonal Antibodies

Trade Names/Brand Names of Ustekinumab

International :

Stelara

Why is Ustekinumab Prescribed? (Indications)

This medication is a monoclonal antibody, prescribed for psoriasis. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.

When should Ustekinumab not be taken? (Contraindications)

Hypersensitivity.

What is the dosage of Ustekinumab?

SC- For patients weighing less than 100kg - The recommended dose is 45 mg initially and 4 weeks later, followed by 45 mg every 12 weeks.
For patients weighing more than 100kg- The recommended dose is 90 mg initially and 4 weeks later, followed by 90 mg every 12 weeks.

How should Ustekinumab be taken?

It comes as a solution for injection to be administered by a healthcare provider under the skin.

What are the warnings and precautions for Ustekinumab?

• Caution should be exercised in patients with history of infection, tuberculosis (TB), cancer, nerve disorder called reversible posterior leukoencephalopathy syndrome (RPLS), poor immunity, flu-like symptoms, received a vaccine, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• TB skin test should be performed before using this medication.

• Avoid contact with people who infections that can be spread to others.

• Avoid live vaccination during the treatment period.

♦ Patient may develop increased risk of infections. If it is so consult with your healthcare provider.

♦ It may increase the risk of malignancy.

What are the side effects of Ustekinumab?

Cold, upper respiratory tract infection, headache, fatigue, diarrhea, back pain, dizziness, throat pain, itching, injection site redness, muscle pain and depression.